<ѻýҕl>Novel Agent Lessens Mucositis in Head and Neck Cancersѻýҕl> IV infusion could allow more patients to complete treatment regimen Jun 06, 2022
<ѻýҕl>Tiragolumab Fails in Extensive-Stage Small Cell Lung Cancerѻýҕl> No change in survival when combined with atezolizumab and chemotherapy Jun 06, 2022
<ѻýҕl>Liquid Biopsy May Save Colon Cancer Patients From Chemoѻýҕl> Circulating tumor DNA could determine who needs more therapy Jun 06, 2022
<ѻýҕl>Endocrine Switch Plus Ribociclib Active in Post-CDK4/6 Inhibitor Progressionѻýҕl> First randomized support for strategy in progressive metastatic HR+/HER2- breast cancer Jun 06, 2022
<ѻýҕl>Myeloma Trial Supports 'Personalized Approach' to Upfront Transplantѻýҕl> DETERMINATION confirms benefit in triple-therapy setting, but suggests timing can be tailored Jun 06, 2022
<ѻýҕl>Complete Responses in 100% of dMMR Rectal Cancer With Neoadjuvant PD-1 Inhibitionѻýҕl> Chemo, RT, surgery avoided in short-term follow-up but study population was small Jun 05, 2022
<ѻýҕl>Trastuzumab Deruxtecan Ushers in New Treatment Era for HER2-Low Breast Cancerѻýҕl> DESTINY-Breast04 extends agent's benefits to historically tough-to-treat disease Jun 05, 2022
<ѻýҕl>Will High-Dose Ifosfamide Become the Go-To Therapy in Recurrent Ewing Sarcoma?ѻýҕl> Data from European rEECur trial "are potentially practice changing," expert says Jun 05, 2022
<ѻýҕl>Third-Line BTK Inhibitor Combo Doubles PFS in Follicular Lymphomaѻýҕl> Significantly more responses, CRs with zanubrutinib-obinutuzumab versus anti-CD20 drug alone Jun 05, 2022
<ѻýҕl>Capivasertib-Fulvestrant Combo Ups Survival in ER+/HER2- Metastatic Breast Cancerѻýҕl> But benefit seems to be predominantly in patients with PI3K/AKT/PTEN pathway alterations Jun 05, 2022
<ѻýҕl>Sacituzumab Govitecan Boosts PFS in Late-Line HR+/HER2- Metastatic Breast Cancerѻýҕl> "This may be something that really changes the lives of these women for the better," expert says Jun 05, 2022
<ѻýҕl>Immunotherapy Rechallenge in NSCLC Yields Overall Survival Boostѻýҕl> Phase II trial sees "synergistic benefit" with checkpoint blockade and anti-angiogenesis Jun 04, 2022
<ѻýҕl>IL-15 Agonist Impresses in Non-Muscle Invasive Bladder Cancerѻýҕl> High response rate, 99%-100% cancer-specific survival at 2 years Jun 04, 2022
<ѻýҕl>Brentuximab Vedotin-Chemo Boosts EFS in High-Risk Pediatric Hodgkin Lymphomaѻýҕl> Combo regimen offers "a new standard for front-line therapy," researcher says Jun 04, 2022
<ѻýҕl>KRAS Inhibitor Shrinks Tumors in Over 40% of NSCLC Patientsѻýҕl> Median survival surpasses 1 year in heavily pretreated population Jun 03, 2022
<ѻýҕl>Bariatric Surgery Cuts Cancer Incidence, Death Riskѻýҕl> Study looked at people with obesity who underwent two most popular procedures Jun 03, 2022
<ѻýҕl>5-Year Interval for Cervical Cancer Screening Safe in HPV-Negative Womenѻýҕl> U.K. study also supports accuracy of HPV testing versus cytology Jun 03, 2022
<ѻýҕl>Colonoscopy With a Computer-Aided Device Boosted Adenoma Detectionѻýҕl> Use of the device led to a 27% increase in adenomas per colonoscopy versus standard procedure Jun 03, 2022
<ѻýҕl>Add-On Ibrutinib Boosts PFS in Untreated, Older Mantle-Cell Lymphoma Patientsѻýҕl> BTK inhibitor plus chemoimmunotherapy increased progression-free survival by over 2 years Jun 03, 2022
<ѻýҕl>Survival Bump With EGFR Inhibitor for KRAS Wild-Type Pancreatic Cancerѻýҕl> But generalizability of "notable" Chinese study questioned Jun 03, 2022
<ѻýҕl>AI Shows Promise in Predicting Optimal Margin Width for CRC Liver Metsѻýҕl> A 7-mm margin width linked with prolonged survival Jun 02, 2022
<ѻýҕl>Adjuvant Everolimus Fails to Stop Recurrence in Early High-Risk Breast Cancerѻýҕl> More than half of everolimus-treated patients permanently discontinued treatment Jun 02, 2022
<ѻýҕl>T-Cell Receptor Gene Therapy Shows Promise in Pancreatic Cancerѻýҕl> Novel treatment targeting KRAS G12D expression induces deep and durable response Jun 01, 2022
<ѻýҕl>FDA Pulls Lymphoma Approvals for PI3K Inhibitor Umbralisibѻýҕl> Worse overall survival observed despite improvements in progression-free survival Jun 01, 2022
<ѻýҕl>Doc Gets Prison for COVID 'Cure'; Proton Therapy Gold Rush; Blackfeet Opioid Crisisѻýҕl> This past week in healthcare investigations Jun 01, 2022
<ѻýҕl>Increased Public Assistance Tied to Better Cancer Survival in Black Patientsѻýҕl> Disparity in 5-year OS declined by more than 40% with each 10% boost in public welfare spending May 31, 2022
<ѻýҕl>Is U.S. 'Getting Its Money's Worth' When It Comes to Cancer Care?ѻýҕl> Cost/mortality benefit pales in comparison with other high-income countries, according to study May 31, 2022
<ѻýҕl>Prone Beats Supine Positioning for WBRT in Women With Large Breastsѻýҕl> Prone position led to lower rates of moist desquamation May 27, 2022
<ѻýҕl>Cancer Outcome Disparities Not Fully Explained by Race, Socioeconomic Factorsѻýҕl> Worse 5-year OS in Hispanic children with high-risk neuroblastoma in adjusted analysis May 27, 2022
<ѻýҕl>Unprecedented PFS Improvement in Relapsed Multiple Myelomaѻýҕl> Three-year median with addition of isatuximab to proteasome inhibitor backbone May 26, 2022
<ѻýҕl>Black Patients Often Never Given a Chance to Join Breast Cancer Trialsѻýҕl> But survey finds several actionable findings that could boost enrollment May 26, 2022
<ѻýҕl>COVID Increased Use of Telemedicine for Cancer Care, Though Not Equitablyѻýҕl> Black, uninsured, non-urban patients less likely to use these services May 26, 2022
<ѻýҕl>Just How Effective Is PSA Screening?ѻýҕl> Study finds test has better benefit/harm trade-off than originally thought May 18, 2022
<ѻýҕl>Younger People More Likely to Undergo Colonoscopy After Guideline Changeѻýҕl> But most colonoscopies still done in those ages 50-54 May 17, 2022
<ѻýҕl>Mental Health Issues Common, Often Overlooked in Prostate Cancerѻýҕl> More than a third of patients with anxiety, depression, fear of recurrence/disease progression May 17, 2022
<ѻýҕl>Urologists Are Helping Combat the Opioid Epidemic, Studies Suggestѻýҕl> Three reports show success in reducing opioid prescribing May 16, 2022
<ѻýҕl>Robotic Surgery Wins for Keeping Bladder Cancer Patients Alive, Out of Hospitalѻýҕl> Approach bested open surgery in iROC trial, but is the difference clinically important? May 15, 2022
<ѻýҕl>Combo Treatment Scores Big in BCG-Unresponsive Bladder Cancerѻýҕl> Significantly durable response with VesAnktiva-Bacillus Calmette-Guérin duo May 15, 2022
<ѻýҕl>Concerning Spike in Barrett's Esophagus, Esophageal Cancer in Middle-Age Adultsѻýҕl> Should these patients undergo screening, especially if they have risk factors? May 15, 2022
<ѻýҕl>Vaginal Estrogen 'Underutilized' in Women With GSM After Breast Cancerѻýҕl> Prescribing rate is half that of women with no breast cancer history May 13, 2022